According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is 7,95ย โฌ. In 2025 the company made an earnings per share (EPS) of -3,69ย โฌ an increase over its 2024 EPS that were of -6,13ย โฌ.